Issues Impacting Medication Adherence: What Does the Law Say About Access to Medications?

Lynn S Muller1

  • 1Lynn S. Muller, JD, BA-HCM, RN, CCM, is an attorney and independent professional case manager. She is an adjunct professor in the MSN and DNP programs at Saint Peter's University of New Jersey where she received her bachelor's degree in Healthcare Management. Lynn is a registered nurse licensed in New York and New Jersey and has been certified case manager for 25 years with extensive nursing and case management experience. Her law practice includes defense of health care professionals before state licensing boards, case management litigation, civil litigation, Wills, Trusts and Estates, and Family law. Lynn is a consultant on such issues as regulatory compliance and accreditation. She has served her community as Councilwoman, Public Defender, and Municipal Court Judge and volunteers as an Early Settlement Panelist for the Family Court. Lynn is the Contributing Editor of the Professional Case Management journal, the official journal of CMSA, and has authored more than 40 articles and the legal chapters of the 3rd and 4th editions of Case Management: A Practical Guide for Education and authored the legal chapter of the 3rd edition of the CMSA Core Curriculum for Case Management and the Legal and Ethical Issues Chapter of Leadership & Nursing Care Management (6th ed.). Lynn is a contributor to the CMSA Career & Knowledge Pathways Project and Standards of Practice for Case Management. She is a contributor to the CCMC Case Management Body of Knowledge (CMBOK). Lynn is as a former commissioner and a member of the ethics committee for CCMC and a past president of the N.J. Chapter of CMSA. She is currently a member of the Board of Directors of CMSA of New York City.

Abstract

No abstract available in PubMed .

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
814
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
265
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
220
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
369
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
352
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
312